All In MedTech

Device Trial Radar · NCT07646938

MolecuLight All-in-One Oxygenation Clinical Utility

A Prospective, Clinical Evaluation of the MolecuLightDX+ With OxySight Module to Observe the Clinical Utility of Tissue Oxygenation, Bacterial Fluorescence and Thermal Signatures

Last checked: Nov 19, 2026Latest source record: Jul 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

18

Actual

Start

Mar 25, 2026

Primary completion

Mar 27, 2026

Study completion Mar 27, 2026

Sponsor

Lead sponsor
MolecuLight Inc.Not on our public-company list
Sponsor type
Industry
First posted
Jun 15, 2026

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years

Summary

As written by the sponsor on the registry.

This is a prospective, clinical evaluation of the MolecuLightDX+ with OxySight Module in wound care.

Conditions

  • Wounds

Interventions

  • MolecuLightDX+ with OxySight ModuleDevice

    MolecuLightDX+ with OxySight Module is an imaging device intended to acquire fluorescence, oxygenation, thermal, and measurement images of wounds.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Tissue oxygenation informing fluorescence-guided debridementTime frame: up to 1 month
  2. Tissue oxygenation changes before and after debridementTime frame: up to 1 month

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • SerenaGroup Monroeville

    Monroeville, Pennsylvania

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.